Skip to content

Brain Activity, Cognitive Function, and Walking Ability in Parkinson's Disease

Brain Activity, Cognitive Function, and Walking Ability in People With Parkinson's Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06588920
Enrollment
70
Registered
2024-09-19
Start date
2024-10-09
Completion date
2027-08-31
Last updated
2026-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Older Adults, Parkinson Disease

Keywords

Executive function, Gait, Electroencephalography

Brief summary

The dual-task automated walking performance in people with Parkinson's disease (PD) is affected by their gait disturbances and impaired executive functions. Currently, the relationship between brain activity related to inhibitory control, executive functions, and dual-task walking performance in people with PD is not well understood. Therefore, this study aims to investigate the significance of different executive function domains on gait stability in healthy older adults and people with PD; whether brain activation related to inhibitory control is associated with gait stability in healthy older adults and people with PD.

Interventions

BEHAVIORALCognitive function, gait, and electroencephalogram

Measurement of cognitive function, gait performance, and electroencephalogram

Sponsors

National Yang Ming Chiao Tung University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnoses of idiopathic Parkinson disease * Stable dopaminergic medicine ≥ 2 weeks * Able to walk 10 meters without aid * Mini-Mental Status Examination ≥ 24 points * No uncorrected visual or auditory disorders * Education at least junior high school * No other disease may affect balance

Exclusion criteria

* Other medical diagnoses of neurological, musculoskeletal, or cardiopulmonary disorders * History of brain surgery (e.g. deep brain stimulation)

Design outcomes

Primary

MeasureTime frameDescription
Gait variability1 dayUsing GAITRite system to measure the coefficient of variation (CV). The mean and standard deviation will be used to calculate the coefficient of variation (CV). CV = standard deviation / mean \* 100%
Gait speed1 dayUsing GAITRite system to measure gait speed.
Step length1 dayUsing GAITRite system to measure step length
Step width1 dayUsing GAITRite system to measure step width.
Single support time1 dayUsing GAITRite system to measure single support time
Double support time1 dayUsing GAITRite system to measure double support time
Frontal Assessment Battery1 dayThe score ranged from 0 to 18. Higher scores show better executive function.
Trail making test1 dayTrail making test contain part A and part B. Faster completing the test indicates better executive function.
Stroop color and word test1 dayRecord numbers of corrected color words which the subject responds within 45 sec.
Digit span test1 dayDigit span test contain forward and backward part. Scores of forward digit span ranges from 0 to 16. Score of backward digit span ranges from 0 to 14. Higher scores indicate better executive function.
Event-related potential - N21 dayMeasure event-related potential through electroencephalography under single-task and dual-task paradigm.
Event-related potential - P3001 dayMeasure event-related potential through electroencephalography under single-task and dual-task paradigm.
Go/Nogo test1 dayBehavioral test during measuring electroencephalography.

Countries

Taiwan

Contacts

CONTACTYea-Ru Yang, PhD
yryang@nycu.edu.tw+886228267279

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026